Do the needle type and the operator experience influence liver biopsy specimen quality?

• Authors: Ioan Sporea , Alina Popescu , Mircea Focşa , Gabriel Becheanu , Roxana Şirli , Maria Cornianu , Liana Gheorghe , Cristina Prelipcean , Cătălina Mihai , Ion Rogoveanu , Larisa Săndulescu
• Languages of publication: EN

Abstracts

EN

Keywords

EN

Liver biopsy; Biopsy needle; Operator’s experience; Specimen quality

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2013
• Volume: 8
• Issue: 5
• Pages: 669-673

Dates

published

1 - 10 - 2013

online

18 - 9 - 2013

Contributors

author

Ioan Sporea

• Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy ”Victor Babeş” Timişoara, 300482, Timişoara, Romania

author

Alina Popescu

• Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy ”Victor Babeş” Timişoara, 300482, Timişoara, Romania

author

Mircea Focşa

• Department of Medical Informatics, University of Medicine and Pharmacy ”Victor Babeş” Timişoara, 300482, Timişoara, Romania

author

Gabriel Becheanu

• Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, 022328, Bucharest, Romania

author

Roxana Şirli

• Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy ”Victor Babeş” Timişoara, 300482, Timişoara, Romania

author

Maria Cornianu

• Department of Pathology, University of Medicine and Pharmacy ”Victor Babeş” Timişoara, 300482, Timişoara, Romania

author

Liana Gheorghe

• Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, 022328, Bucharest, Romania

author

Cristina Prelipcean

• Department of Gastroenterology, University of Medicine Iaşi, 700115, Iaşi, Romania

author

Cătălina Mihai

• Department of Gastroenterology, University of Medicine Iaşi, 700115, Iaşi, Romania

author

Ion Rogoveanu

• I Medical Department, University of Medicine and Pharmacy Craiova, 200349, Craiova, Romania

author

Larisa Săndulescu

• I Medical Department, University of Medicine and Pharmacy Craiova, 200349, Craiova, Romania

References

• [1] Friedman LS: Controversies in liver biopsy: who, where, when, how and why? Current Gastroenterology Reports 2004;6:30–36 http://dx.doi.org/10.1007/s11894-004-0023-4[Crossref]
• [2] The British Society of Gastroenterology Guidelines on the use of liver biopsy in clinical practice. Gut 1999; 45(Suppl.4): 1–11
• [3] Guido M, Rugge M: Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis Feb 2004; 24(1):89–97 http://dx.doi.org/10.1055/s-2004-823103[Crossref]
• [4] Colloredo G, Guido M, Sonzogni A, Leandro G: Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239–244 http://dx.doi.org/10.1016/S0168-8278(03)00191-0[Crossref]
• [5] Cholongitas E, Senzolo M, Standish R, Marelli L, Quaglia A, Patch D,, et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol. 2006 May;125(5):710–721 http://dx.doi.org/10.1309/W3XCNT4HKFBN2G0B[Crossref]
• [6] Poynard T, Halfon P, Castera L, Charlotte F, Le Bail B, Munteanu M, et al; FibroPaca Group.: Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy lengh and fragmentation. Aliment Pharmacol Ther 2007;25:733–739 http://dx.doi.org/10.1111/j.1365-2036.2007.03252.x[Crossref][WoS]
• [7] Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al: Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004;50:1344–1355 http://dx.doi.org/10.1373/clinchem.2004.032227[Crossref]
• [8] Beaugrand M: (FibroScan instructions for use) Journées Francophones de Pathologie Digestive, Gastroenterol. Clin. Biol. 2006;30:513–514
• [9] de Man RA, van Buuren HR, Hop WC.: A randomised study on the efficacy and safety of an automated TruCut needle for percutaneous liver biopsy. Neth J Med 2004;62:441–445
• [10] Piccinino F, Sagnelli E, Pasquale G, Giusti G: Complications following percutaneous liver biopsy: a multiple retrospective study on 68276 biopsies. J Hepatol 1986;2:165–173 http://dx.doi.org/10.1016/S0168-8278(86)80075-7[Crossref]
• [11] Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, et al: The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996;23:1079–1083 http://dx.doi.org/10.1002/hep.510230522[Crossref]
• [12] Younossi ZM, Teran JC, Ganiats TG, Carey WD: Ultrasound-guided liver biopsy for parenchymal liver diseases: an economical analysis. Dig Dis Sci 1998;43:46–50 http://dx.doi.org/10.1023/A:1018815802500[Crossref]
• [13] Pasha T, Gabriel S, Therneau T, Dickson ER, Lindor KD: Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology 1998;27:1220–1226 http://dx.doi.org/10.1002/hep.510270506[Crossref]
• [14] Poniachik J, Bernstein DE, Reddy KR, Jeffers LJ, Coelho-Little ME, Civantos F, et al: The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996;43:568–571 http://dx.doi.org/10.1016/S0016-5107(96)70192-X[Crossref]
• [15] Pagliaro L, Rinaldi F, Craxì A, Di Piazza S, Filippazzo G, Gatto G, et al: Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci 1983;28:39–43 http://dx.doi.org/10.1007/BF01393359[Crossref]
• [16] Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, et al: Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;1:523–525 http://dx.doi.org/10.1016/S0140-6736(86)90883-4[Crossref]
• [17] Bedossa P, Dargere P, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449–1457 [Crossref]
• [18] Cadranel JF, Rufat P, Degos F: Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology 2000; 32: 477–481 http://dx.doi.org/10.1053/jhep.2000.16602[Crossref]
• [19] Riley TR: How often does ultrasound making change the liver biopsy site. Am J Gastroenterol 1999; 94: 3320–3322 http://dx.doi.org/10.1111/j.1572-0241.1999.01545.x[Crossref]
• [20] Jensen DM: Liver biopsy in the management of hepatitis C: not always required. AGA Perspectives 2005;4:5–12

Identifiers

DOI

10.2478/s11536-012-0148-z